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Crossing Mice Carrying TnT Disease Mutations with Opposite Effects on
the Myofilament Calcium Sensitivity Partially Normalizes Myofilament
Function and Ameliorates Cardiomyopathy Phenotypes
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Mutations in cardiac troponin T (TnT) associated with hypertrophic cardiomy-
opathy (HCM) generally lead to an increase in the calcium (Ca) sensitivity of
contraction. In contrast, TnT mutations linked to dilated cardiomyopathy
(DCM) decrease the Ca sensitivity of contraction.Here we test the hypothesis
that two TnT disease mutations with opposite effects on the myofilament Ca
sensitivity can rescue each other. To test this hypothesis, we crossed transgenic
mice expressing the HCM TnT-I79N mutation with a DCM knock-in (KI)
mouse model carrying the TnT-R141W mutation. Two double-transgenic ani-
mals were studied: I79N/R141Wmut/þ and I79N/R141Wmut/mut which con-
tained the HCM TnT-I79N transgene and either one or two alleles carrying
the DCMTnT-R141Wmutation, respectively. The Ca sensitivity of contraction
was measured in skinned cardiac muscle fibers and compared to WT, I79N TG
and heterozygous R141Wmut/þ KI mice hearts.The results of the Ca sensitivity
ranked from highest to lowest were as follow: I79N > I79N/R141Wmut/þ >
I79N/R141Wmut/mut > WT > R141Wmut/þ. In vivo testing showed that the dou-
ble transgenic mice had reduced arrhythmia susceptibility and tissue fibrosis
compared to I79N TG mice, a hallmark of HCM. Furthermore, the double
transgenic mice had reduced heart/body weight ratio compared to mice car-
rying only the DCM TnT-R141W mutations. These results suggest that car-
rying two disease mutations in TnT that have opposite effects on the
myofilament Ca sensitivity can paradoxically rescue the disease phenotype.
The data further point towards an independent role of changes in the Ca sensi-
tivity in the pathogenesis of DCM and HCM. Future studies will explore the in
vivo cardiac function of the double-transgenic mice.
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Introduction: Many of cTnT mutations linked to cardiomyopathies fall the
TNT1 domain/N terminal tail region of unresolved high definition structure.
This region (~94-170) of cTnT is critical to Tm binding and contraction regu-
lation. Here, the impact of the E163R mutation in cTnT-TNT1 on contractile
function and tension cost was investigated using intact and skinned prepara-
tions from WT and transgenic mouse hearts.
Methods: Left and right ventricular trabeculae were dissected from non-
transgenic wild type (WT) and heterozygous (D160E or E163R) mouse hearts
and mounted isometrically to record twitch tension or, when skinned, Ca2þ
activated force. Myofibrillar ATPase activity was measured by fluorimetric
enzyme coupled assay (de Tombe and Stienen, 1995).
Results: Myocardium of E163R mice shows: (i) no change of myosin isoform
expression (ii) maintained peak isomentric twitch tension at all stimulation fre-
quencies, (iii) prolonged time to peak and time to 50% relaxation, with pre-
served rate-adaptation of twitch duration, (iv) changes of the short-term
interval force relationship and increased occurrence of spontaneous contrac-
tions. No significant differences were found in maximum Ca2þ activated ten-
sion of E163R and WT skinned trabeculae. However, Ca2þ sensitivity of
tension was significantly increased in E163R skinned trabeculae when
compared with WT. As to the economy of force maintenance, preliminary ex-
periments suggest an increase of tension cost in trabeculae from E163R hearts.
Resting ATPase activity also tended to be higher in E163R preparations. Ki-
netics of force development and relaxation will be assessed on single myofi-
brils, isolated from the same hearts.
Conclusions: Both primary sarcomeric changes and secondary E-C coupling al-
terations contribute to mechanical impairment in E163R cTnT mutant myocar-
dium. Supported by: EC Grant n. 241577 (BIG-Heart)1745-Pos Board B475
AAV6-Mediated Overexpression of Ribonucleotide Reductase (R1R2)
Enhances 2-Deoxy-ATP Concentration in Vivo and Improves Cardiac
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Impaired systolic function resulting from acute injury, congenital defect, or
aging can lead to cardiac complications and heart failure. Current therapies
are unable to rescue cardiac function, but merely slow disease progression.
We have demonstrated that when myosin uses 2-deoxy-ATP (dATP) as an
energy substrate for contraction instead of ATP, cardiac contractility is
enhanced by 20% or more. Viral-vector mediated overexpression of R1R2,
the enzyme that catalyzes production of deoxy-nucleotides, increases intra-
cellular dATP. In this study we determined the expression pattern of R1R2
in mice following systemic delivery of recombinant adeno-associated viral
vectors pseudotyped with the type 6 capsid (rAAV6) carrying R1 and R2
subunits, and a cardiac specific gene regulatory cassette (cTnT455). Cardiac
function was assessed in vivo via echocardiography, and ex vivo using Lan-
gendorf perfusion to test the hypothesis that elevating myocardial dATP by a
gene therapy approach enhances cardiac function. We also performed metab-
olomics evaluation of both skeletal and cardiac muscle to correlate with
changes in cardiac function. Our current data suggest that systemic delivery
of this rAAV6 system results in myocardial specific overexpression of R1R2
and improves basal cardiac performance, which supports our previously pub-
lished data for transgenic animals with long-term overexpression of R1R2.
Metabolic analysis suggests that R1R2 overexpression in the heart alone al-
ters the glucose metabolism of both skeletal and cardiac muscle, indicating
improved basal cardiac performance can directly impact skeletal muscle
metabolism. Preliminary studies in an aging model demonstrate that treat-
ment with this rAAV6 vector increases oxidative metabolism in cardiac
tissue and increases glycolysis in fast twitch skeletal muscle. These data
indicate that vector-mediated overexpression of R1R2 improves basal
cardiac function and impacts skeletal muscle metabolism, demonstrating po-
tential to improve cardiac function of patients with systolic dysfunction.
HL11197.
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The giant sarcomeric protein titin spans the length of the half sarcomere and
consists of an I-band region that functions as a molecular spring and a less
well understood A-band region. Here we characterize a mouse model in
which a portion of titin near the A-I junction has been removed(AIKO).
We measured passive stiffness using a muscle mechanics stretch-hold-
release protocol in which a skinned fiber from the left ventricle papillary
was stretched to a given sarcomere length(SL) within the physiological range,
held for 90 seconds, and subjected to a sinusoidal frequency sweep. Active
tensions were measured at SL=2.0mm and SL=2.2mm in both tissue types.
We found that both total and titin-based passive stiffness was significantly
higher in the AI KO compared to WT; at SL=2.3mm peak total passive ten-
sion was 43.5þ/8.3mN/mm2 in the KO compared to 23.5þ/-3.6mN/mm2 in
the WT while peak titin-based passive tension was 28.7þ/-7.0mN/mm2 in
the AI KO compared to 13.8þ/-2.0mN/mm2 in the WT. A similar trend
was observed for total and titin-based steady state passive tensions. No sig-
nificant differences in active tensions were observed at either SL indicating
no major changes to the thick filament or myofilament area; this suggests
the passive tension difference is intrinsic to titin. The sinusoidal frequency
sweep was used to quantify the vicious and elastic modulus. Viscous and
elastic moduli are defined as (s/ε)sin(q) and (s/ε)cos(q) respectively where
346a Monday, February 17, 2014s is stress, ε is strain, and q is the phase shift. We found that both the viscous
modulus and the elastic modulus were higher in the AI KO at high fre-
quencies. These results suggest that WT passive tension levels rely on an
intact A-I junction; the removal of this region results in increased titin
stiffness.
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Myocardial Titin: An Important Modifier of Cardiac Stiffness
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Background: A well-established function of titin is the determination of pas-
sive tension (Fpassive) in myocardium. Modifications to the elastic titin region
have been suggested to contribute to left ventricular (LV) diastolic dysfunction
in heart failure (HF). Titin-based stiffness can be modulated by isoform switch
or phosphorylation.
Results:We find that titin-isoform switch accounts for a significant amount of
myocardial stiffness modulation, giving rise to increased or reduced Fpassive in
different types of heart failure. In addition, both acute and chronic modula-
tions of cardiomyocyte Fpassive occur via altered titin phosphorylation. Cyclic
AMP-dependent protein kinase-A, cGMP-dependent protein kinase-G, and
extracellular signal-regulated kinase-2 phosphorylate titin at a cardiac-
specific domain, the N2Bus; this phosphorylation results in a reduction in car-
diomyocyte Fpassive in various species. PKCa phosphorylates the PEVK-
domain of titin, which increases Fpassive of normal mouse cardiomyocytes,
but does not significantly alter Fpassive of cardiomyocytes obtained from a
dog HF model. Calcium/calmodulin-dependent protein kinase-II (CaMKII)
is the first kinase found to phosphorylate both the N2Bus and the PEVK-
domain. This phosphorylation reduces cardiomyocyte Fpassive, as demonstrated
in skinned mouse cardiomyocytes incubated with recombinant CaMKIId.
Moreover, Fpassive is elevated in cardiomyocytes of CaMKIIg/d double
knockout mice and reduced in those of CaMKIId-overexpressing transgenic
mice. In both human and experimental HF, a global titin phosphorylation
deficit is observed, but site-specific titin phosphorylation can be increased
or decreased in HF, presumably depending on the activity and expression level
of the relevant kinases.
Conclusion: Titin phosphorylation may have beneficial effects in the heart
via reducing myocardial diastolic stiffness and improving ventricular
filling. Altered titin phosphorylation in HF may severely affect Fpassive and
compromise cardiac function. The degree, to which the different protein ki-
nases contribute to alterations in diastolic passive stiffness, needs to be
determined.
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Cardiac myosin binding protein C (cMyBP-C) is a sarcomeric protein involved
in the regulation of cardiac muscle contraction. Effects of cMyBP-C on
contraction are thought to be mediated in part by limiting the interactions of
actin and myosin to slow myocyte shortening velocity and power output.
Although interactions with myosin S2 on the thick filament have been proposed
as a way in which cMyBP-C could limit shortening velocity (e.g., by creating a
drag force on myosin heads), interactions of cMyBP-C with actin could also
account for slowed shortening velocity. For instance, cMyBP-C could create
a drag that opposes filament sliding by transiently linking thick and thin fila-
ments together. To explore this possibility we created transgenic mice that ex-
press a mutant cMyBP-C with a point mutation (L348P) located in a conserved
sequence within the regulatory M-domain that increases cMyBP-C binding to
actin in vitro (Bezold et al, JBC, 2013). We reasoned that if the mutation also
enhanced binding to actin in sarcomeres then shortening velocity would be
slowed in myocytes from L348P mice. Results show that transgenic mice ex-
pressing the L348P mutation are viable and that L348P cMyBP-C is expressed
in sarcomeres. Permeabilized myocytes from transgenic mice showed altered
force production including reduced maximal force and enhanced Ca2þ sensi-
tivity of tension. Shortening velocity and power output were significantly
reduced whereas passive stiffness and myocyte visco-elasticity were signifi-
cantly increased. Together these data are consistent with the idea that
cMyBP-C creates an internal load in the sarcomere by binding to actin. Thiswork supported by NIH R01 HL080367 (SPH) and an AHA graduate fellow-
ship (KLB).
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Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiac
disorder. Mutations in the gene (MYBPC3) encoding cardiac myosin binding
protein C (cMyBP-C) are a frequent cause of HCM. Clinical as well as
animal-model studies have reported sex-related differences in HCM disease
onset and severity. In addition, it has been established that physiological
stimuli such as exercise may elicit a sexually dimorphic cardiac response.
However, less attention has been paid to the sex-specific differences in the
cellular pathophysiologic mechanisms underlying HCM. Therefore, we
studied functional properties of the heart and sarcomeres in male and
female sedentary and exercise (exposed to 8 weeks voluntary wheel running)
mice.
Echocardiography and isometric force measurements in mechanically isolated
left ventricular (LV) membrane-permeabilized cardiomyocytes were per-
formed in Wild-type (WT) and heterozygous (HET) knock-in mice carrying
a Mybpc3 point mutation (G>A transition) associated with HCM.
The LV mass was significantly lower in female WT and HET mice (23% in
WT and 25% in HET), compared to corresponding male mice. Isometric
force measurements revealed a significant lower maximal generated tension
(Fmax) in HET male (13.0 51.1 kN/m
2), than in females (20.0 52.2 kN/
m2). Exercise induced a higher fractional shortening in HET male mice,
which is correlated with an increased Fmax in exercised HET males. In
contrast, LV weight was significantly increased in exercised HET females
compared to sedentary females (7% in WT and 15% in HET). Ca2þ-sensi-
tivity was increased in exercised male and females WT mice. Similarly,
Ca2þ-sensitivity was enhanced in HET females, however not in exercised
HET mice.
In conclusion, exercise training improved cardiac and myofilament perfor-
mance particularly in HET male mice, indicating that physiological stimuli
may elicit a sexually dimorphic cardiac response in heterozygous Mybpc3-tar-
geted knock-in mice.
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Background
Hypertrophic cardiomyopathy (HCM) is an inherited cardiac disorder with a
prevalence of 1:500. In ~65% of all HCM patients the causative mutation is
identified. HCM patients that are sarcomere-mutation negative tend to have a
less severe phenotype. Mutations in the MYBPC3 and MYH7 genes encoding
cardiac myosin-binding protein C (cMyMP-C) and b-myosin heavy chain
(MyHC) represent >80% of all genotyped HCM cases. HCM is characterized
by asymmetric hypertrophy of the left ventricle and diastolic dysfunction. In
the present study we investigated if passive stiffness of the sarcomeres may un-
derlie diastolic dysfunction.
Methods
In-vitro passive tension measurements were done at sarcomere lengths of 1.8 to
2.2mm in cardiomyocytes from 10 sarcomere mutation-negative patients(SMN:
5 male, 5 female), 17 patients carrying a MYBPC3 mutation(MYBPC3: 10
male, 7 female), and 10 patients carrying a MYH7 mutation (MYH7: 5 male,
5 female). Tissue was obtained during myectomy surgery from the interventric-
ular septum. Cardiomyocytes were mechanically isolated and Triton-
permeabilized.
